Abiopharma

🔍 Bestwick Andrew Joseph (Executive)

Company: Rigetti Computing, Inc. (RGTI)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 750,000 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,041,912.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,791 shares of Common Stock at $16.8053 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,036,121.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Represents an award of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. One-sixteenth (1/16th) of the total number of RSUs (rounded down, except for the final scheduled vesting installment) will vest on the 20th day of the middle month of each quarter (i.e., February 20, May 20, August 20 and November 20) commencing on November 20, 2026, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
• F2: The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $16.965, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.